Compactable oral formulations of ibutamoren
US11969416B1 · kind B1 · utility
1Cited by
5References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 22, 2022 |
| Grant date | Apr 30, 2024 |
| Priority date | — |
| Expiry date | Nov 22, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P5/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to pharmaceutical solid forms and pharmaceutical compositions comprising ibutamoren or a pharmaceutically acceptable salt thereof, and methods for administering to a pediatric subject for treating growth hormone deficiency.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.